Redhill Biopharma Ltd (NASDAQ:RDHL)

5.01
Delayed Data
As of Apr 20
 +0.08 / +1.62%
Today’s Change
4.30
Today|||52-Week Range
11.25
-2.53%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 20.00, with a high estimate of 51.42 and a low estimate of 17.00. The median estimate represents a +299.20% increase from the last price of 5.01.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.67
Sales
$2.0M
Reporting Date
May 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.52%
 
 
 
 
 
 
Growthannually 30.77%
 
 
 
 
 
 

Sales

Growthquarterly 1.82%
 
 
 
 
 
 
Growthannually 207.49%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.